Cardiolipin and mitochondrial function in health and disease

Antioxidants and Redox Signaling

Volumn 20, Issue 12, 2014, Pages 1925-1953

  Paradies, Giuseppe ^a   Paradies, Valeria ^a   Ruggiero, Francesca M ^a   Petrosillo, Giuseppe ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CARDIOLIPIN; PHOSPHOLIPID;

AGING; BACTERIAL MEMBRANE; BARTH SYNDROME; BIOENERGY; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROCHEMISTRY; ENERGY TRANSFER; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; LIPOGENESIS; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REPERFUSION INJURY; RESPIRATORY CHAIN; REVIEW; THYROID DISEASE; DISEASES; ENERGY METABOLISM; PHYSIOLOGY;

CARDIOLIPINS; DISEASE; ENERGY METABOLISM; HUMANS; MITOCHONDRIA;

EID: 84897092477     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5280     Document Type: Review

References (242)

1. Acehan D, Malhotra A, Xu Y, Ren M, Stokes DL, and Schlame M. Cardiolipin affects the supramolecular organization of ATP synthase in mitochondria. Biophys J 100: 2184-2192, 2011
2. Acehan D, Vaz F, Houtkooper RH, James J, Moore V, Tokunaga C, Kulik W, Wansapura J, Toth MJ, Strauss A, and Khuchua Z. Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J Biol Chem 286: 899-908, 2011
3. Acín-Pérez R, Fernández-Silva P, Peleato ML, Pérez-Martos A, and Enriquez JA. Respiratory active mitochondrial supercomplexes. Mol Cell 32: 529-539, 2008
4. Adams JM and Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science 281: 1322-1326, 1998
5. Aldakkak M, Stowe DF, Dash RK, and Camara AK. Mitochondrial handling of excess Ca2 + is substrate-dependent with implications for reactive oxygen species generation. Free Radic Biol Med 56: 193-203, 2013
6. Allen RD, Schroeder CC, and Fok AK. An investigation of mitochondrial inner membranes by rapid-freeze deep-etch techniques. J Cell Biol 108: 2233-2240, 1989
7. Ambrosio G, Zweier JL, and Flaherty JT. The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion. J Mol Cell Cardiol 12: 1359-1374, 1991
8. Ardail D, Privat JP, Egret-Charlier M, Levrat C, Lerme F, and Louisot P. Mitochondrial contact sites. Lipid composition and dynamics. J Biol Chem 265: 18797-18802, 1990
9. Arnold I, Pfeiffer K, Neupert W, Stuart RA, and Schägger H. Yeast mitochondrial F1F0-ATP synthase exists as a dimer: Identification of three dimer-specific subunits. EMBO J 17: 7170-7178, 1998
10. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, and Molkentin JD. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434: 658-662, 2005
11. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, and Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9: 550-555, 2007
12. Ban T, Heymann JA, Song Z, Hinshaw JE, and Chan DC. OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. Hum Mol Genet 19: 2113-2122, 2010
13. Barth PG, Scholte HR, Berden JA, Van der Klei-Van Moorsel JM, Luyt-Houwen E, Van 't Veer-Korthof ET, Van der Harten JJ, and Sobotka-Plojhar MA. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62: 327-355, 1983
14. Basso E, Petronilli V, Forte MA, and Bernardi P. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation. J Biol Chem 283: 26307-26311, 2008
15. Bayir H, Fadeel B, Palladino MJ, Witasp E, Kurnikov IV, Tyurina YY, Tyurin VA, Amoscato AA, Jiang J, Kochanek PM, DeKosky ST, Greenberger JS, Shvedova AA, and Kagan VE. Apoptotic interactions of cytochrome c: Redox flirting with anionic phospholipids within and outside of mitochondria. Biochim Biophys Acta 1757: 648-659, 2006
16. Bayir H, Kapralov AA, Jiang J, Huang Z, Tyurina YY, Tyurin VA, Zhao Q, Belikova NA, Vlasova II, Maeda A, Zhu J, Na HM, Mastroberardino PG, Sparvero LJ, Amoscato AA, Chu CT, Greenamyre JT, and Kagan VE. Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: Protection against apoptosis versus delayed oxidative stress in Parkinson disease. J Biol Chem 284: 15951-15969, 2009
17. Beckman KB and Ames BN. The free radical theory of aging matures. Physiol Rev 78: 547-581, 1998
18. Begriche K, Igoudjil A, Pessayre D, and Fromenty B. Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it. Mitochondrion 6: 1-28, 2006
19. Belikova NA, Vladimirov YA, Osipov AN, Kapralov AA, Tyurin VA, Potapovich MV, Basova LV, Peterson J, Kurnikov IV, and Kagan VE. Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes. Biochemistry 45: 4998-5009, 2006
20. Beranek A, Rechberger G, Knauer H, Wolinski H, Kohlwein SD, and Leber R. Identification of a cardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeast. J Biol Chem 284: 11572-11578, 2009
21. Beyer K and Klingenberg M. ADP/ATP carrier protein from beef heart mitochondria has high amounts of tightly bound cardiolipin, as revealed by 31P nuclear magnetic resonance. Biochemistry 24: 3821-3826, 1985
22. Bianchi C, Genova ML, Parenti Castelli G, and Lenaz G. The mitochondrial respiratory chain is partially organized in a supercomplex assembly: Kinetic evidence using flux control analysis. J Biol Chem 279: 36562-36569, 2004
23. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, and Toniolo D. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 12: 385-389, 1996
24. Bisaccia F and Palmieri F. Specific elution from hydroxylapatite of the mitochondrial phosphate carrier by cardiolipin. Biochim Biophys Acta 766: 386-394, 1984
25. Bolhuis PA, Hensels GW, Hulsebos TJ, Baas F, and Barth PG. Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am J Hum Genet 48: 481-485, 1991
26. Boveris A and Chance B. The mitochondrial generation of hydrogen peroxide: General properties and effect of hyperbaric oxygen. Biochem J 134: 707-716, 1973
27. Brandner K, Mick DU, Frazier AE, Taylor RD, Meisinger C, and Rehling P. Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: Implications for Barth Syndrome. Mol Biol Cell 16: 5202-5214, 2005
28. Brustovetsky N and Klingenberg M. Mitochondrial ADP/ ATP carrier can be reversibly converted into a large channel by Ca2 + . Biochemistry 35: 8483-8488, 1996
29. Büeler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol 218: 235-246, 2009
30. Butler J, Jayson GG, and Swallow AJ. The reaction between the superoxide anion radical and cytochrome c. Biochim Biophys Acta 408: 215-222, 1975
31. Camara AK, Bienengraeber M, and Stowe DF. Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol 2:13, 2011
32. Cao J, Liu Y, Lockwood J, Burn P, and Shi Y. A novel cardiolipin- remodeling pathway revealed by a gene encoding an endoplasmic reticulum-Associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J Biol Chem 279: 31727-31734, 2004
33. Cereghetti GM and Scorrano L. The many shapes of mitochondrial death. Oncogene 25: 4717-4724, 2006
34. Cerveny KL, Tamura Y, Zhang Z, Jensen RE, and Sesaki H. Regulation of mitochondrial fusion and division. Trends Cell Biol 17: 563-569, 2007
35. Chen D, Zhang XY, and Shi Y. Identification and functional characterization of hCLS1, a human cardiolipin synthase localized in mitochondria. Biochem J 398: 169-176, 2006
36. Chen S, He Q, and Greenberg ML. Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth. Mol Microbiol 68: 1061-1072, 2008
37. Chicco AJ and Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 292: C33-C44, 2007
38. Chipuk JE, Bouchier-Hayes L, and Green DR. Mitochondrial outer membrane permeabilization during apoptosis: The innocent bystander scenario. Cell Death Differ 8: 1396-1402, 2006
39. Chitturi S and Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21: 27-41, 2001
40. Choi SY, Huang P, Jenkins GM, Chan DC, Schiller J, and Frohman MA. A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat Cell Biol 11: 1255-1262, 2006
41. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, and Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 4 Suppl 1: S60-S67, 2007
42. Claypool SM, McCaffery JM, and Koehler CM. Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins. J Cell Biol 174: 379-390, 2006
43. Claypool SM, Oktay Y, Boontheung P, Loo JA, and Koehler CM. Cardiolipin defines the interactome of the major ADP/ ATP carrier protein of the mitochondrial inner membrane. J Cell Biol 182: 937-950, 2008
44. Claypool SM. Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochim Biophys Acta 1788: 2059-2068, 2009
45. Cole NB, Dieuliis D, Leo P, Mitchell DC, and Nussbaum RL. Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. Exp Cell Res 314: 2076-2089, 2008
46. Crompton M, Ellinger H, and Costi A. Inhibition by cyclosporin A of a Ca2 +-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255: 357-360, 1988
47. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 (Pt 2): 233-249, 1999
48. Cullis PR and de Kruijff B. Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim Biophys Acta 559: 399-420, 1979
49. Daum G. Lipids of mitochondria. Biochim Biophys Acta 822: 1-42, 1985
50. de Kroon AI, Dolis D, Mayer A, Lill R, and de Kruijff B. Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membranéBiochim Biophys Acta 1325: 108-116, 1997
51. DeVay RM, Dominguez-Ramirez L, Lackner LL, Hoppins S, Stahlberg H, and Nunnari J. Coassembly of Mgm1 isoforms requires cardiolipin and mediates mitochondrial inner membrane fusion. J Cell Biol 186: 793-803, 2009
52. Dowhan W. Molecular basis for membrane phospholipid diversity: Why are there so many lipids?Annu Rev Biochem 66: 199-232, 1997
53. Eble KS, Coleman WB, Hantgan RR, and Cunningham CC. Tightly associated cardiolipin in the bovine heart mitochondrial ATP synthase as analyzed by 31P nuclear magnetic resonance spectroscopy. J Biol Chem 265: 19434-19440, 1990
54. Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barceló-Coblijn GC, and Nussbaum RL. Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein. Mol Cell Biol 25: 10190-10201, 2005
55. Epand RF, Martinou JC, Fornallaz-Mulhauser M, Hughes DW, and Epand RM. The apoptotic protein tBid promotes leakage by altering membrane curvature. J Biol Chem 277: 32632-32639, 2002
56. Epand RF, Schlattner U, Wallimann T, Lacombe ML, and Epand RM. Novel lipid transfer property of two mitochondrial proteins that bridge the inner and outer membranes. Biophys J 92: 126-137, 2007
57. Epand RF, Tokarska-Schlattner M, Schlattner U, Wallimann T, and Epand RM. Cardiolipin clusters and membrane domain formation induced by mitochondrial proteins. J Mol Biol 365: 968-980, 2007
58. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, and Scorrano L. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126: 177-189, 2006
59. Fry M and Green DE. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. J Biol Chem 256: 1874-1880, 1981
60. Fyfe PK, McAuley KE, Roszak AW, Isaacs NW, Cogdell RJ, and Jones MR. Probing the interface between membrane proteins and membrane lipids by X-ray crystallography. Trends Biochem Sci 26: 106-112, 2001
61. Gadicherla AK, Stowe DF, Antholine WE, Yang M, and Camara AK. Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-Anginal drug ranolazine. Biochim Biophys Acta 1817: 419-429, 2012
62. Gallas MR, Dienhart MK, Stuart RA, and Long RM. Characterization of Mmp37p, a Saccharomyces cerevisiae mitochondrial matrix protein with a role in mitochondrial protein import. Mol Biol Cell 17: 4051-4062, 2006
63. Garcia Fernandez M, Troiano L, Moretti L, Nasi M, Pinti M, Salvioli S, Dobrucki J, and Cossarizza A. Early changes in intramitochondrial cardiolipin distribution during apoptosis. Cell Growth Differ 13: 449-455, 2002
64. Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M, Glick GD, Petronilli V, Zoratti M, Szabó I, Lippe G, and Bernardi P. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 110: 5887-5892, 2013
65. Gomez B, Jr. and Robinson NC. Phospholipase digestion of bound cardiolipin reversibly inactivates bovine cytochrome bc1. Biochemistry 38: 9031-9038, 1999
66. Gómez LA, Monette JS, Chavez JD, Maier CS, and Hagen TM. Supercomplexes of the mitochondrial electron transport chain decline in the aging rat heart. Arch Biochem Biophys 490: 30-35, 2009
67. Gonzalvez F and Gottlieb E. Cardiolipin: Setting the beat of apoptosis. Apoptosis 12: 877-885, 2007
68. Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJ, Petit PX, Vaz FM, and Gottlieb E. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 183: 681-696, 2008
69. Grijalba MT, Vercesi AE, and Schreier S. Ca2 +-induced increased lipid packing and domain formation in submitochondrial particles. A possible early step in the mechanism of Ca2 +-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry 38: 13279-13287, 1999
70. Gu Z, Valianpour F, Chen S, Vaz FM, Hakkaart GA, Wanders RJ, and Greenberg ML. Aberrant cardiolipin metabolism in the yeast taz1 mutant: A model for Barth syndrome. Mol Microbiol 51: 149-158, 2004
71. Hackenbrock CR, Chazotte B, and Gupte SS. The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport. J Bioenerg Biomembr 18: 331-368, 1986
72. Haines TH and Dencher NA. Cardiolipin: A proton trap for oxidative phosphorylation. FEBS Lett 528: 35-39, 2002
73. Halestrap AP, Clarke SJ, and Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-A target for cardioprotection. Cardiovasc Res 61: 372-385, 2004
74. Halestrap AP and Davidson AM. Inhibition of Ca2 (+)-induced large-Amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-Trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 268: 153-160, 1990
75. Halestrap AP. Calcium, mitochondria and reperfusion injury: A pore way to die. Biochem Soc Trans 34: 232-237, 2006
76. Halestrap AP. Mitochondrial permeability: Dual role for the ADP/ATP translocator?Nature 430: 1 p following 983, 2004
77. Han X, Abendschein DR, Kelley JG, and Gross RW. Diabetes-induced changes in specific lipid molecular species in rat myocardium. Biochem J 15 Pt 1: 79-89, 2000
78. Han X, Yang J, Cheng H, Yang K, Abendschein DR, and Gross RW. Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 44: 16684-16694, 2005
79. Han X, Yang J, Yang K, Zhao Z, Abendschein DR, and Gross RW. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: A shotgun lipidomics study. Biochemistry 46: 6417-6428, 2007
80. Hausenloy DJ and Yellon DM. The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35: 339-341, 2003
81. Heerdt PM, Schlame M, Jehle R, Barbone A, Burkhoff D, and Blanck TJ. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg 73: 1216-1221, 2002
82. Herlan M, Vogel F, Bornhovd C, Neupert W, and Reichert AS. Processing of Mgm1 by the rhomboid-Type protease Pcp1 is required for maintenance of mitochondrial morphology and of mitochondrial DNA. J Biol Chem 278: 27781-27788, 2003
83. Higami Y and Shimokawa I. Apoptosis in the aging process. Cell Tissue Res 301: 125-132, 2000
84. Hoch FL. Cardiolipins and biomembrane function. Biochim Biophys Acta 1113: 71-133, 1992
85. Hoffmann B, Stöckl A, Schlame M, Beyer K, and Klingenberg M. The reconstituted ADP/ATP carrier activity has an absolute requirement for cardiolipin as shown in cysteine mutants. J Biol Chem 269: 1940-1944, 1994
86. Hoppins S, Lackner L, and Nunnari J. The machines that divide and fuse mitochondria. Annu Rev Biochem 76: 751-780, 2007
87. Hostetler KY. Effect of thyroxine on the activity of mitochondrial cardiolipin synthase in rat liver. Biochim Biophys Acta 1086: 139-140, 1991
88. Houtkooper RH, Turkenburg M, Poll-The BT, Karall D, Pérez- Cerdá C, Morrone A, Malvagia S, Wanders RJ, Kulik W, and Vaz FM. The enigmatic role of tafazzin in cardiolipin metabolism. Biochim Biophys Acta 1788: 2003-2014, 2009
89. Houtkooper RH and Vaz FM. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci 65: 2493-2506, 2008
90. Hung T, Sievenpiper JL, Marchie A, Kendall CW, and Jenkins DJ. Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease. Curr Opin Clin Nutr Metab Care 6: 165-176, 2003
91. Hüttemann M, Pecina P, Rainbolt M, Sanderson TH, Kagan VE, Samavati L, Doan JW, and Lee I. The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis. Mitochondrion 11: 369-381, 2011
92. Imai H, Koumura T, Nakajima R, Nomura K, and Nakagawa Y. Protection from inactivation of the adenine nucleotide translocator during hypoglycaemia-induced apoptosis by mitochondrial phospholipid hydroperoxide glutathione peroxidase. Biochem J 371: 799-809, 2003
93. Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, Potapovich AI, Kini V, Amoscato AA, and Fujii Y. Oxidative lipidomics of apoptosis: Redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic Biol Med 37: 1963-1985, 2004
94. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, and Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223-232, 2005
95. Kajstura J, Cheng W, Sarangarajan R, Li P, Li B, Nitahara JA, Chapnick S, Reiss K, Olivetti G, and Anversa P. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol 271: H1215-H1228, 1996
96. Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K, Eimer S, Winklhofer KF, and Haass C. Inhibition of mitochondrial fusion by a-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29: 3571-3589, 2010
97. Kapralov AA, Kurnikov IV, Vlasova II, Belikova NA, Tyurin VA, Basova LV, Zhao Q, Tyurina YY, Jiang J, Bayir H, Vladimirov YA, and Kagan VE. The hierarchy of structural transitions induced in cytochrome c by anionic phospholipids determines its peroxidase activation and selective peroxidation during apoptosis in cells. Biochemistry 46: 14232-14244, 2007
98. Kim TH, Zhao Y, Ding WX, Shin JN, He X, Seo YW, Chen J, Rabinowich H, Amoscato AA, and Yin XM. Bid-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome C release. Mol Biol Cell 7: 3061-3072, 2004
99. Klingen AR, Palsdottir H, Hunte C, and Ullmann GM. Redox-linked protonation state changes in cytochrome bc1 identified by Poisson-Boltzmann electrostatics calculations. Biochim Biophys Acta 1767: 204-221, 2007
100. Klingenberg M. Cardiolipin and mitochondrial carriers. Biochim Biophys Acta 1788: 2048-2058, 2009
101. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, and Wallace DC. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427: 461-465, 2004
102. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny MV, Malorni W, Knight RA, Piacentini M, Nagata S, Melino G; Nomenclature Committee on Cell Death. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 12 Suppl 2: 1463-1467, 2005
103. Kulik W, van Lenthe H, Stet FS, Houtkooper RH, Kemp H, Stone JE, Steward CG, Wanders RJ, and Vaz FM. Bloodspot assay using HPLC-Tandem mass spectrometry for detection of Barth syndrome. Clin Chem 54: 371-378, 2008
104. Kutik S, Rissler M, Guan XL, Guiard B, Shui G, Gebert N, Heacock PN, Rehling P, Dowhan W, Wenk MR, Pfanner N, and Wiedemann N. The translocator maintenance protein Tam41 is required for mitochondrial cardiolipin biosynthesis. J Cell Biol 183: 1213-1221, 2008
105. Laird DM, Eble KS, and Cunningham CC. Reconstitution of mitochondrial F0.F1-ATPase with phosphatidylcholine using the nonionic detergent, octylglucoside. J Biol Chem 261: 14844-14850, 1986
106. Lange C, Nett JH, Trumpower BL, and Hunte C. Specific roles of protein-phospholipid interactions in the yeast cytochrome bc1 complex structure. EMBO J 20: 6591-6600, 2001
107. Lecocq J and Ballou CE. On the structure of cardiolipin. Biochemistry 3: 976-980, 1964
108. Lenaz G, Bovina C, Castelluccio C, Fato R, Formiggini G, Genova ML, Marchetti M, Pich MM, Pallotti F, Parenti Castelli G, and Biagini G. Mitochondrial complex I defects in aging. Mol Cell Biochem 174: 329-333, 1997
109. Lenaz G and Genova ML. Structure and organization of mitochondrial respiratory complexes: A new understanding of an old subject. Antioxid Redox Signal 12: 961-1008, 2010
110. Lesnefsky EJ, Slabe TJ, Stoll MS, Minkler PE, and Hoppel CL. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 280: H2770-H2778, 2001
111. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, and Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 3: 183-192, 2002
112. Leung AW, Varanyuwatana P, and Halestrap AP. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem 283: 26312-26323, 2008
113. Liu J, Dai Q, Chen J, Durrant D, Freeman A, Liu T, Grossman D, and Lee RM. Phospholipid scramblase 3 controls mitochondrial structure, function, and apoptotic response. Mol Cancer Res 12: 892-902, 2003
114. Liu X, Kim CN, Yang J, Jemmerson R, and Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86: 147-157, 1996
115. Lu B, Xu FY, Jiang YJ, Choy PC, Hatch GM, Grunfeld C, and Feingold KR. Cloning and characterization of a cDNA encoding human cardiolipin synthase (hCLS1). J Lipid Res 47: 1140-1145, 2006
116. Ludwig J, McGill DB, and Lindor KD. Review: Nonalcoholic steatohepatitis. J Gastroenterol Hepatol 12: 398-403, 1997
117. Luo X, Budihardjo I, Zou H, Slaughter C, and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998
118. Lutter M, Fang M, Luo X, Nishijima M, Xie X, and Wang X. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol 2: 754-761, 2000
119. Lutter M, Perkins GA, and Wang X. The pro-Apoptotic Bcl-2 family member tBid localizes to mitochondrial contact sites. BMC Cell Biol 2: 22, 2001
120. Ma ZA, Zhao Z, and Turk J. Mitochondrial dysfunction and b-cell failure in type 2 diabetes mellitus. Exp Diabetes Res 2012: 703538, 2012
121. Malhotra A, Xu Y, Ren M, and Schlame M. Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species. Biochim Biophys Acta 1791: 314-320, 2009
122. Mancuso DJ, Kotzbauer P, Wozniak DF, Sims HF, Jenkins CM, Guan S, Han X, Yang K, Sun G, Malik I, Conyers S, Green KG, Schmidt RE, and Gross RW. Genetic ablation of calcium-independent phospholipase A2{gamma} leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction. J Biol Chem 284: 35632-35644, 2009
123. Marchetti P, Lupi R, Del Guerra S, Bugliani M, Marselli L, and Boggi U. The beta-cell in human type 2 diabetes. Adv Exp Med Biol 654: 501-514, 2010
124. Marom M, Safonov R, Amram S, Avneon Y, Nachliel E, Gutman M, Zohary K, Azem A, and Tsfadia Y. Interaction of the Tim44 C-Terminal domain with negatively charged phospholipids. Biochemistry 48: 11185-11195, 2009
125. McAuley KE, Fyfe PK, Ridge JP, Isaacs NW, Cogdell RJ, and Jones MR. Structural details of an interaction between cardiolipin and an integral membrane protein. Proc Natl Acad Sci U S A 96: 14706-14711, 1999
126. McCord JM. Free radicals and myocardial ischemia: Overview and outlook. Free Radic Biol Med 4: 9-14, 1988
127. McKenzie M, Lazarou M, Thorburn DR, and Ryan MT. Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients. J Mol Biol 361: 462-469, 2006
128. Miquel J, Economos AC, Fleming J, and Johnson JE, Jr. Mitochondrial role in cell aging. Exp Gerontol 15: 575-591, 1980
129. Miyata H, Lakatta EG, Stern MD, and Silverman HS. Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ Res 71: 605-613, 1992
130. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, and Kagawa Y. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163: 1450-1455, 1989
131. Mizushima T, Yao M, Imoue N, Aoyama H, Yamashita E, Yamaguchi H, et al. Structure of phospholipids in a membrane protein complex, bovine heart cytochrome c oxidase. Acta Crystallogr A (Suppl) 55: P06.04.069, 1999
132. Mulligan CM, Sparagna GC, Le CH, De Mooy AB, Routh MA, Holmes MG, Hickson-Bick DL, Zarini S, Murphy RC, Xu FY, Hatch GM, McCune SA, Moore RL, and Chicco AJ. Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. Cardiovasc Res 94: 460-468, 2012
133. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009
134. Musatov A. Contribution of peroxidized cardiolipin to inactivation of bovine heart cytochrome c oxidase. Free Radic Biol Med 41: 238-246, 2006
135. Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J, Gardner B, Wakabayashi J, Sesaki H, Cheng Y, Finkbeiner S, Nussbaum RL, Masliah E, and Edwards RH. Direct membrane association drives mitochondrial fission by the Parkinson diseaseassociated protein alpha-synuclein. J Biol Chem 286: 20710-20726, 2011
136. Na1ecz KA, Kamiń ska J, Na1ecz MJ, and Azzi A. The activity of pyruvate carrier in a reconstituted system: Substrate specificity and inhibitor sensitivity. Arch Biochem Biophys 297: 162-168, 1992
137. Navarro A and Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292: C670-C686, 2007
138. Noél H and Pande SV. An essential requirement of cardiolipin for mitochondrial carnitine acylcarnitine translocase activity. Lipid requirement of carnitine acylcarnitine translocase. Eur J Biochem 155: 99-102, 1986
139. Nohl H and Stolze K. Ubisemiquinones of the mitochondrial respiratory chain do not interact with molecular oxygen. Free Radic Res Commun 16: 409-419, 1992
140. Novgorodov SA, Gudz TI, Kushnareva YE, Zorov DB, and Kudrjashov YB. Effect of ADP/ATP antiporter conformational state on the suppression of the nonspecific permeability of the inner mitochondrial membrane by cyclosporine A. FEBS Lett 277: 123-126, 1990
141. Nury H, Dahout-Gonzalez C, Trézéguet V, Lauquin G, Brandolin G, and Pebay-Peyroula E. Structural basis for lipid-mediated interactions between mitochondrial ADP/ ATP carrier monomers. FEBS Lett 579: 6031-6036, 2005
142. Nury H, Dahout-Gonzalez C, Trézéguet V, Lauquin GJ, Brandolin G, and Pebay-Peyroula E. Relations between structure and function of the mitochondrial ADP/ATP carrier. Annu Rev Biochem 75: 713-741, 2006
143. Oliveira CP, da Costa Gayotto LC, Tatai C, Della Bina BI, Janiszewski M, Lima ES, Abdalla DS, Lopasso FP, Laurindo FR, and Laudanna AA. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med 6: 399-406, 2002
144. O'Rourke B and Reibel DK. Effects of adrenoceptor blockade on cardiac hypertrophy and myocardial phospholipids. Proc Soc Exp Biol Med 200: 95-100, 1992
145. Orrenius S, Zhivotovsky B, and Nicotera P. Regulation of cell death: The calcium-Apoptosis link. Nat Rev Mol Cell Biol 4: 552-565, 2003
146. Osman C, Haag M, Potting C, Rodenfels J, Dip PV, Wieland FT, Brügger B, Westermann B, and Langer T. The genetic interactome of prohibitins: Coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria. J Cell Biol 184: 583-596, 2009
147. Osman C, Haag M, Wieland FT, Brügger B, and Langer T. A mitochondrial phosphatase required for cardiolipin biosynthesis: The PGP phosphatase Gep4. EMBO J 29: 1976-1987, 2010
148. Osteryoung KW and Nunnari J. The division of endosymbiotic organelles. Science 302: 1698-1704, 2003
149. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, and Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A 99: 1259-1263, 2002
150. Palmieri F. The mitochondrial transporter family (SLC25): Physiological and pathological implications. Pflugers Arch 447: 689-709, 2004
151. Paradies G, Paradies V, Ruggiero FM, and Petrosillo G. Changes in the mitochondrial permeability transition pore in aging and age-Associated diseases. Mech Ageing Dev 134: 1-9, 2013
152. Paradies G, Petrosillo G, Paradies V, and Ruggiero FM. Mitochondrial dysfunction in brain aging: Role of oxidative stress and cardiolipin. Neurochem Int 58: 447-457, 2011
153. Paradies G, Petrosillo G, Paradies V, and Ruggiero FM. Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging. Free Radic Biol Med 48: 1286-1295, 2010
154. Paradies G, Petrosillo G, Paradies V, and Ruggiero FM. Role of cardiolipin peroxidation and Ca2 + in mitochondrial dysfunction and disease. Cell Calcium 45: 643-650, 2009
155. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A, and Ruggiero FM. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: Involvement of reactive oxygen species and cardiolipin. Circ Res 94: 53-59, 2004
156. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Serena D, and Ruggiero FM. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic Biol Med 27: 42-50, 1999
157. Paradies G, Petrosillo G, Pistolese M, and Ruggiero FM. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 286: 135-141, 2002
158. Paradies G, Petrosillo G, Pistolese M, and Ruggiero FM. Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles. Mitochondrion 1: 151-159, 2001
159. Paradies G, Petrosillo G, Pistolese M, and Ruggiero FM. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett 466: 323-326, 2000
160. Paradies G, Petrosillo G, and Ruggiero FM. Cardiolipindependent decrease of cytochrome c oxidase activity in heart mitochondria from hypothyroid rats. Biochim Biophys Acta 1319: 5-8, 1997
161. Paradies G, Ruggiero FM, Dinoi P, Petrosillo G, and Quagliariello E. Decreased cytochrome oxidase activity and changes in phospholipids in heart mitochondria from hypothyroid rats. Arch Biochem Biophys 307: 91-95, 1993
162. Paradies G, Ruggiero FM, and Dinoi P. The influence of hypothyroidism on the transport of phosphate and on the lipid composition in rat-liver mitochondria. Biochim Biophys Acta 1070: 180-186, 1991
163. Paradies G, Ruggiero FM, Petrosillo G, and Quagliariello E. Alterations in carnitine-Acylcarnitine translocase activity and in phospholipid composition in heart mitochondria from hypothyroid rats. Biochim Biophys Acta 1362: 193-200, 1997
164. Paradies G, Ruggiero FM, Petrosillo G, and Quagliariello E. Enhanced cytochrome oxidase activity and modification of lipids in heart mitochondria from hyperthyroid rats. Biochim Biophys Acta 1225: 165-170, 1994
165. Paradies G, Ruggiero FM, Petrosillo G, and Quagliariello E. Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid rats. FEBS Lett 397: 260-262, 1996
166. Paradies G and Ruggiero FM. Enhanced activity of the tricarboxylate carrier and modification of lipids in hepatic mitochondria from hyperthyroid rats. Arch Biochem Biophys 278: 425-430, 1990
167. Paradies G and Ruggiero FM. Stimulation of phosphate transport in rat-liver mitochondria by thyroid hormones. Biochim Biophys Acta 1019: 133-136, 1990
168. Pebay-Peyroula E, Dahout-Gonzalez C, Kahn R, Trézéguet V, Lauquin GJ, and Brandolin G. Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 426: 39-44, 2003
169. Pessayre D and Fromenty B NASH: A mitochondrial disease. J Hepatol 42: 928-940, 2005
170. Peter ME and Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10: 26-35, 2003
171. Petrosillo G, Casanova G, Matera M, Ruggiero FM, and Paradies G. Interaction of peroxidized cardiolipin with ratheart mitochondrial membranes: Induction of permeability transition and cytochrome c release. FEBS Lett 580: 6311-6316, 2006
172. Petrosillo G, Colantuono G, Moro N, Ruggiero FM, Tiravanti E, Di Venosa N, Fiore T, and Paradies G. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 297: H1487-H1493, 2009
173. Petrosillo G, Di Venosa N, Pistolese M, Casanova G, Tiravanti E, Colantuono G, Federici A, Paradies G, and Ruggiero FM. Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia-reperfusion: Role of cardiolipin. FASEB J 20: 269-276, 2006
174. Petrosillo G, Matera M, Casanova G, Ruggiero FM, and Paradies G. Mitochondrial dysfunction in rat brain with aging Involvement of complex I, reactive oxygen species and cardiolipin. Neurochem Int 53: 126-131, 2008
175. Petrosillo G, Matera M, Moro N, Ruggiero FM, and Paradies G. Mitochondrial complex I dysfunction in rat heart with aging: Critical role of reactive oxygen species and cardiolipin. Free Radic Biol Med 46: 88-94, 2009
176. Petrosillo G, Moro N, Paradies V, Ruggiero FM, and Paradies G. Increased susceptibility to Ca(2 +)-induced permeability transition and to cytochrome c release in rat heart mitochondria with aging: Effect of melatonin. J Pineal Res 48: 340-346, 2010
177. Petrosillo G, Moro N, Ruggiero FM, and Paradies G. Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic Biol Med 47: 969-974, 2009
178. Petrosillo G, Portincasa P, Grattagliano I, Casanova G, Matera M, Ruggiero FM, Ferri D, and Paradies G. Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta 1767: 1260-1267, 2007
179. Petrosillo G, Ruggiero FM, Di Venosa N, and Paradies G. Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: Role of reactive oxygen species and cardiolipin. FASEB J 17: 714-716, 2003
180. Petrosillo G, Ruggiero FM, Pistolese M, and Paradies G. Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef-heart submitochondrial particles via cardiolipin peroxidation. Possible role in the apoptosis. FEBS Lett 509: 435-438, 2001
181. Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML, and Schägger H. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 278: 52873-52880, 2003
182. Pop C and Salvesen GS. Human caspases: Activation, specificity, and regulation. J Biol Chem 284: 21777-21781, 2009
183. Pranke IM, Morello V, Bigay J, Gibson K, Verbavatz JM, Antonny B, and Jackson CL. a-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J Cell Biol 194: 89-103, 2011
184. Protter D, Lang C, and Cooper AA. aSynuclein and mitochondrial dysfunction: A pathogenic partnership in Parkinson's diseaséParkinsons Dis 2012: 829207, 2012
185. Riccio P, Aquila H, and Klingenberg M. Purification of the carboxy-Atractylate binding protein from mitochondria. FEBS Lett 56: 133-138, 1975
186. Robinson NC. Functional binding of cardiolipin to cytochrome c oxidase. J Bioenerg Biomembr 25: 153-163, 1993
187. Saini-Chohan HK, Holmes MG, Chicco AJ, Taylor WA, Moore RL, McCune SA, Hickson-Bick DL, Hatch GM, and Sparagna GC. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure. J Lipid Res 50: 1600-1608, 2009
188. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, and Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687, 1998
189. Schägger H and Pfeiffer K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J 19: 1777-1783, 2000
190. Schägger H. Respiratory chain supercomplexes of mitochondria and bacteria. Biochim Biophys Acta 1555: 154-159, 2002
191. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, and Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827, 1990
192. Schlame M and Haldar D. Cardiolipin is synthesized on the matrix side of the inner membrane in rat liver mitochondria. J Biol Chem 268: 74-79, 1993
193. Schlame M and Hostetler KY. Cardiolipin synthase from mammalian mitochondria. Biochim Biophys Acta 1348: 207-213, 1997
194. Schlame M and Hostetler KY. Solubilization, purification, and characterization of cardiolipin synthase from rat liver mitochondria. Demonstration of its phospholipid requirement. J Biol Chem 266: 22398-22403, 1991
195. Schlame M and Ren M. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580: 5450-5455, 2006
196. Schlame M and Ren M. The role of cardiolipin in the structural organization of mitochondrial membranes. Biochim Biophys Acta 1788: 2080-2083, 2009
197. Schlame M, Rua D, and Greenberg ML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 39: 257-288, 2000
198. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, and Blanck TJ. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51: 634-637, 2002
199. Schlame M, Zhao M, Rua D, Haldar D, and Greenberg ML. Kinetic analysis of cardiolipin synthase: A membrane enzyme with two glycerophospholipid substrates. Lipids 30: 633-640, 1995
200. Schlame M. Cardiolipin remodeling and the function of tafazzin. Biochim Biophys Acta 1831: 582-588, 2013
201. Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res 49: 1607-1620, 2008
202. Schlattner U, Tokarska-Schlattner M, Ramirez S, Brückner A, Kay L, Polge C, Epand RF, Lee RM, Lacombe ML, and Epand RM. Mitochondrial kinases and their molecular interaction with cardiolipin. Biochim Biophys Acta 1788: 2032-2047, 2009
203. Schlattner U and Wallimann T. Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding. J Biol Chem 275: 17314-17320, 2000
204. Schmidt O, Pfanner N, and Meisinger C. Mitochondrial protein import: From proteomics to functional mechanisms. Nat Rev Mol Cell Biol 11: 655-667, 2010
205. Schug ZT and Gottlieb E. Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. Biochim Biophys Acta 1788: 2022-2031, 2009
206. Schwall CT, Greenwood VL, and Alder NN. The stability and activity of respiratory Complex II is cardiolipindependent. Biochim Biophys Acta 1817: 1588-1596, 2012
207. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA, and Korsmeyer SJ. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2: 55-67, 2002
208. Sedlák E and Robinson NC. Phospholipase A(2) digestion of cardiolipin bound to bovine cytochrome c oxidase alters both activity and quaternary structure. Biochemistry 38: 14966-14972, 1999
209. Sharpley MS, Shannon RJ, Draghi F, and Hirst J. Interactions between phospholipids and NADH:ubiquinone oxidoreductase (complex I) from bovine mitochondria. Biochemistry 45: 241-248, 2006
210. Shigenaga MK, Hagen TM, and Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A 91: 10771-10778, 1994
211. Sinibaldi F, Howes BD, Piro MC, Polticelli F, Bombelli C, Ferri T, Coletta M, Smulevich G, and Santucci R. Extended cardiolipin anchorage to cytochrome c: A model for proteinmitochondrial membrane binding. J Biol Inorg Chem 15: 689-700, 2010
212. Skulachev VP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett 423: 275-280, 1998
213. Song Z, Chen H, Fiket M, Alexander C, and Chan DC. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol 178: 749-755, 2007
214. Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, axey ML, McCune SA, and Moore RL. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res 48: 1559-1570, 2007
215. Sparagna GC, Johnson CA, McCune SA, Moore RL, and Murphy RC. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J Lipid Res 46: 1196-1204, 2005
216. Stowe DF and Camara AK. Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function. Antioxid Redox Signal 11: 1373-1414, 2009
217. Szabó I and Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Lett 330: 201-205, 1993
218. Taylor WA and Hatch GM. Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J Biol Chem 278: 12716-12721, 2003
219. Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, and Yoshikawa S. The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 272: 1136-1144, 1996
220. Tuominen EK, Wallace CJ, and Kinnunen PK. Phospholipid-cytochrome c interaction: Evidence for the extended lipid anchorage. J Biol Chem 277: 8822-8826, 2002
221. Tuominen EK, Zhu K, Wallace CJ, Clark-Lewis I, Craig DB, Rytomaa M, and Kinnunen PK. ATP induces a conformational change in lipid-bound cytochrome c. J Biol Chem 276: 19356-19362, 2001
222. Turrens JF, Alexandre A, and Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237: 408-414, 1985
223. Tyurin VA, Tyurina YY, Feng W, Mnuskin A, Jiang J, Tang M, Zhang X, Zhao Q, Kochanek PM, Clark RS, Bayir H, and Kagan VE. Mass-spectrometric characterization of phospholipids and their primary peroxidation products in rat cortical neurons during staurosporine-induced apoptosis. J Neurochem 107: 1614-1633, 2008
224. Unger RH. Lipotoxic diseases. Annu Rev Med 53: 319-336, 2002
225. Valianpour F, Mitsakos V, Schlemmer D, Towbin JA, Taylor JM, Ekert PG, Thorburn DR, Munnich A, Wanders RJ, Barth PG, and Vaz FM. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J Lipid Res 46: 1182-1195, 2005
226. Vanden Hoek TL, Becker LB, Shao Z, Li C, and Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273: 18092-18098, 1998
227. Vanden Hoek TL, Li C, Shao Z, Schumacker PT, and Becker LB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 29: 2571-2583, 1997
228. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, and Barth PG. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 279: 378-382, 2000
229. Walker JE. The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains. Q Rev Biophys 25: 253-324, 1992
230. Weiss C, Oppliger W, Vergères G, Demel R, JenöP, Horst M, de Kruijff B, Schatz G, and Azem A. Domain structure and lipid interaction of recombinant yeast Tim44. Proc Natl Acad Sci U S A 96: 8890-8894, 1999
231. Weiss H, Friedrich T, Hofhaus G, and Preis D. The respiratory-chain NADH dehydrogenase (complex I) of mitochondria. Eur J Biochem 197: 563-576, 1991
232. Wittig I, Carrozzo R, Santorelli FM, and Schägger H. Supercomplexes and subcomplexes of mitochondrial oxidative phosphorylation. Biochim Biophys Acta 1757: 1066-1072, 2006
233. Xu Y, Condell M, Plesken H, Edelman-Novemsky I, Ma J, Ren M, and Schlame M. A Drosophila model of Barth syndrome. Proc Natl Acad Sci U S A 103: 11584-11588, 2006
234. Xu Y, Malhotra A, Ren M, and Schlame M. The enzymatic function of tafazzin. J Biol Chem 281: 39217-39224, 2006
235. Yan LJ and Sohal RS. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci U S A 95: 12896-12901, 1998
236. Yin H and Zhu M. Free radical oxidation of cardiolipin: Chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases. Free Radic Res 46: 959-974, 2012
237. Youle RJ and Karbowski M. Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 6: 657-663, 2005
238. Zambrano F, Fleischer S, and Fleischer B. Lipid composition of the Golgi apparatus of rat kidney and liver in comparison with other subcellular organelles. Biochim Biophys Acta 380: 357-369, 1975
239. Zhang M, Mileykovskaya E, and Dowhan W. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J Biol Chem 280: 29403-29408, 2005
240. Zhang M, Mileykovskaya E, and Dowhan W. Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277: 43553-43556, 2002
241. Zhao M, Schlame M, Rua D, and Greenberg ML. Cardiolipin synthase is associated with a large complex in yeast mitochondria. J Biol Chem 273: 2402-2408, 1998
242. Zoratti M, Szabò I, and De Marchi U. Mitochondrial permeability transitions: How many doors to the houséBiochim Biophys Acta 1706: 40-52, 2005.